Join GSK Integrated Symposia at ECCMID 2022 to learn more about the need to address uUTI patient burden due to the impact of increasing antibiotic resistance in community practice.

We are pleased to also invite you to join our panel of multi-disciplinary experts, as they discuss the challenges and opportunities to fight AMR in the community setting.

Integrated Symposia at ECCMID 2022

This material is for healthcare professionals only.
For educational purposes.
These educational activities are funded and organised by GSK.
For more information or if you suspect an adverse event or other human safety information, contact the GlaxoSmithKline Medical Department - 
+351 214129500 - or send an email to lis.nucleo-farmacovigilancia@gsk.com.
GlaxoSmithKline – Produtos Farmacêuticos, Lda, Rua Dr. António Loureiro Borges nº3, Arquiparque – Miraflores, 1499-013 Algés NIF 500 139 962
NX-GBL-GPT-AGND-220005  Date of preparation: March 2022

You have received this email as a contact of ESCMID or one of its affiliated societies.
You can unsubscribe here.